glp 1 agonist risks GLP-1 Agonists in Cardiovascular Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies GLP-1 receptor agonists are increasingly
Description
Osteoclast number on the surface of trabecular bone was observed by histological analysis, which demonstrated a significant decrease after 16 weeks of exendin-4 use in OVX rats (10)
To overcome this limitation, the pharmaceutical industry developed GLP-1 analogs, compounds designed to mimic the hormones action while extending its duration
Bergman., A
Asmar A, Simonsen L, Asmar M, Madsbad S, Holst JJ, Frandsen E, et al
Additional information Enhanced Digital Features To view enhanced digital features for this article go to Electronic supplementary material Below is the link to the electronic supplementary material
